Skip to content

Ardelyx ARDX Weighted Average Exercise Price of Vested and Expected to Vest Options

Weighted Average Exercise Price of Vested and Expected to Vest Options at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.

The official record: Ardelyx’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's weighted average exercise price of vested and expected to vest options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's weighted average exercise price of vested and expected to vest options?
Ardelyx (ARDX) reported weighted average exercise price of vested and expected to vest options of $5.54 in Q4 2025.
How has Ardelyx's weighted average exercise price of vested and expected to vest options changed year-over-year?
Ardelyx's weighted average exercise price of vested and expected to vest options decreased by 1.6% year-over-year, from $5.63 to $5.54.
What is the long-term trend for Ardelyx's weighted average exercise price of vested and expected to vest options?
Over 4 years (2021 to 2025), Ardelyx's weighted average exercise price of vested and expected to vest options has grown at a -5.7% compound annual growth rate (CAGR), from $7.00 to $5.54.
What does weighted average exercise price of vested and expected to vest options mean?
The average price at which holders of vested and expected-to-vest stock options can purchase company shares. This metric serves as a benchmark for the alignment between employee incentives and shareholder value creation. Changes in this price reflect the company's historical equity valuation and the potential future dilution impact of option exercises.